Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD.Kareem Abu‐Elmagd, Thomas E. Starzl, John J. Fung et al.|Journal of the American College of Surgeons|1998Cited by 264
AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF EPSTEIN-BARR VIRUS-POSITIVE AND -NEGATIVE LYMPHOPROLIFERATIVE DISORDERS ARISING IN ORGAN TRANSPLANT RECIPIENTS1Michael A. Nalesnik, Thomas E. Starzl, Theresa L. Whiteside et al.|Transplantation|1997Cited by 109